Blog - Page 3866 of 5600

ThursdayJan 28, 2010 10:12 am

ImmuneRegen BioSciences, Inc. (IRBS.OB) to Work with NIH

Yesterday, IR Biosciences Holdings’ wholly owned subsidiary, ImmuneRegen BioSciences Inc., announced the execution of an agreement with the National Institute of Health to commence studies utilizing the company’s Homspera. As per the agreement, the NIH will perform exploratory studies on Homspera relating to mucosal immunity that could possibly lead to evaluation in models of HIV infection. Recent studies have shown Homspera to enhance the efficacy of a novel cancer vaccine. Previous studies have yielded the same results related to infectious disease vaccines, specifically influenza. The studies to be performed at NIH will expand on the previous research and will further…

ThursdayJan 28, 2010 10:06 am

Miller Petroleum (MILL) Announces Six Million in Equity Investment

Miller Petroleum closed on a $6 million equity investment from an unnamed third party. The funds will be used for capital expenditures related to a recent acquisition by the company. In December 2009, Miller Petroleum purchased the oil and gas operations of Pacific Energy Resources, a company that was in Chapter 11 bankruptcy proceedings. The company did not disclose a price. Pacific Energy Resources had proved reserves of 5.6 million barrels of oil and 3.7 billion cubic feet (bcf) of natural gas located in Alaska. The discounted net present value of the reserves as calculated under SEC regulations is $325…

ThursdayJan 28, 2010 10:03 am

CrowdGather, Inc. (CRWG.OB) Announces Successful Completion of Social Media Marketing Campaign

CrowdGather, Inc., one of the leading networks of forum communities on the Internet, recently announced that the company has completed the delivery of an integrated advertising and social media marketing campaign through its CrowdBlu website to an undisclosed client. Launched in December 2009, the marketing campaign included run-of-network display advertising, user surveys and user-generated video contest. CrowdGather’s management team intends to leverage the success of this campaign to secure new clients for its integrated viral marketing services. CrowdGather provides highly interactive and informational social network services and management of revenue-sharing resources for third-party forum owners. The CrowdBlu website (www.crowdblue.com) promotes…

ThursdayJan 28, 2010 10:01 am

Pacific Bepure Industry Inc. (PBEP.OB) Expects to Post 25% Hike in FY 2009 Sales

Despite a slow first-half in 2009, Pacific Bepure Industry Inc., one of China’s leading footwear companies, yesterday announced a spike in domestic footwear sales that contributed to a 25 percent increase in full-year sales. The company’s four lines of Travel Time casual and sports shoes are popular among young women in smaller cities in China. Pacific Bepure manufactures the footwear and sells them in 22 provinces through retail stores and various other outlets, including the Internet and a distributor in South America. Pacific Bepure said it was able to balance sales by maintaining cost control, generating increases in margins for…

ThursdayJan 28, 2010 9:47 am

Consorteum Holdings Inc. (CSRH.OB) Secures Private Placement Financing

Consorteum Holdings, Inc. was pleased to announce this morning that it has reached an agreement to raise additional financing with private investors. According to the press release, these investors have already had an investment interest in the company. This agreement will provide for an initial investment of up to $1,000,000 USD in the first two fiscal quarters of 2010. Consorteum will use the funds to enhance the delivery schedules of current contracts as well as to pursue additional contracts in North American and International markets. This marks the first 2010 financial engagement for Consorteum Holdings as it focuses on new…

WednesdayJan 27, 2010 4:48 pm

Novelos Therapeutics, Inc. (NVLT.OB) Nearly Doubled in Price Since Coverage by QualityStocks Newsletter

Novelos Therapeutics Inc.’s shares have nearly doubled in price since the company was initially covered in QualityStocks’ FREE Daily Newsletter. Novelos was mentioned in the newsletter only a few short weeks ago – on December 15, 2009 – when the stock was trading for only $1.09 a share. Since then the stock has climbed to a current price of $2.07 a share. That is a spectacular rise in such a short time! Novelos Therapeutics is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. The company's lead compound – NOV-002 – is in Phase 2…

WednesdayJan 27, 2010 3:47 pm

National Automation Services, Inc. (NASV.PK) is “One to Watch”

National Automation Services, Inc. is a public holding company focused on designing, engineering, installing and maintaining automated control systems for such business applications as waste water treatment, water treatment, airport security, bottling plants, power plants, metals, mining, breweries, food processing, tire making, textiles, plastics and nearly all production activities. Dominant players in the $500 Billion national and international automation controls market include Siemens, Honeywell, Fisher Controls, Johnson Controls and others. In addition to the multi-nationals, it has been estimated that there could be as many as 900 local and regional firms providing automation control services. In general, these companies have…

WednesdayJan 27, 2010 2:53 pm

Ready Mix Inc. (RMX) Works to Position Itself for a South-Western US Rebound

Risk is all part of the equation when it comes to investing. If a particular sector or company appears to be at a low, there may well be opportunity for long-term profit if that sector turns around. The prospect of a loss is always there but so is the prospect of a very large profit. In a general way, this perspective all depends upon one's tolerance for risk and reward. Ready Mix Inc., a manufacturer, distributor and installer of readymade concrete, works to mine and mix concrete for the full spectrum of construction opportunities. The company works primarily in the…

WednesdayJan 27, 2010 2:49 pm

Dynavax Technologies Corp. (DVAX) is “One to Watch”

Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious diseases. They discover and develop a pipeline of Toll-like Receptor (TLR) product candidates. The Company's clinical-stage product candidates include Phase 3 HEPLISAV ™ Hepatitis B Vaccine, Phase 1 Hepatitis C Therapy, and Phase 1 Hepatitis B Therapy. Dynavax Technologies Corporation trades on the NASDAQ Capital Market. The Company's lead product candidate HEPLISAV™ is a Phase 3 investigational adult hepatitis B vaccine designed to provide more rapid and increased protection with fewer doses than current licensed vaccines. Their global strategy is…

WednesdayJan 27, 2010 2:44 pm

Imagine Media Ltd. (IMLE.OB) Inks LOI to Acquire Biotech Firm DMI Life Sciences

Imagine Media Ltd. today announced it has signed a non-binding Letter of Intent to acquire DMI Life Sciences Inc., a biotechnology firm engaged in developing pharmaceutical products and medical devices. If the acquisition does take place, DMI shareholders will acquire roughly 91 percent of total issued and outstanding shares of Imagine Media. For DMI, becoming a publicly traded company will accelerate its trek of obtaining executing future plans. “Gaining access to the public markets will enable us to achieve our goals much sooner, and give our shareholders the value and liquidity they deserve. With a large and diverse portfolio, DMI…

Site Search

Company Search